Singular Genomics Systems (NASDAQ:OMIC – Get Rating) is one of 43 public companies in the “Analytical instruments” industry, but how does it weigh in compared to its rivals? We will compare Singular Genomics Systems to similar businesses based on the strength of its profitability, dividends, institutional ownership, risk, valuation, analyst recommendations and earnings. Profitability This […]